HR 1725 114th Congress House Health Congressional oversight Criminal justice information and records Drug trafficking and controlled substances Drug, alcohol, tobacco use Health information and medical records Health programs administration and funding Health technology, devices, supplies Licensing and registrations Medical research Prescription drugs State and local government operations

National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015

Introduced: March 26, 2015 See on congress.gov

Everywhere this bill has been 16 steps

Introduced

In committee

Reported out

Passed House

Passed Senate

To President

Became law

Sep 9, 2015

Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Sep 8, 2015

Motion to reconsider laid on the table Agreed to without objection.

Sep 8, 2015

On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5796-5797)

Sep 8, 2015

Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H5796-5797)

Sep 8, 2015

DEBATE - The House proceeded with forty minutes of debate on H.R. 1725.

Sep 8, 2015

Considered under suspension of the rules. (consideration: CR H5796-5798)

Sep 8, 2015

Mr. Guthrie moved to suspend the rules and pass the bill, as amended.

Sep 8, 2015

Placed on the Union Calendar, Calendar No. 186.

Sep 8, 2015

Reported by the Committee on Energy and Commerce. H. Rept. 114-245.

Jul 29, 2015

Ordered to be Reported by Voice Vote.

Jul 29, 2015

Committee Consideration and Mark-up Session Held.

Jul 23, 2015

Forwarded by Subcommittee to Full Committee by Voice Vote .

Jul 23, 2015

Subcommittee Consideration and Mark-up Session Held.

Mar 27, 2015

Referred to the Subcommittee on Health.

Mar 26, 2015

Referred to the House Committee on Energy and Commerce.

Mar 26, 2015

Introduced in House

Plain-English summary Congressional Research Service

National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015

(Sec. 2) Amends the National All Schedules Prescription Electronic Reporting Act of 2005 to include as a purpose of state-administered controlled substance monitoring systems ensuring access to prescription history information for the investigative purposes of appropriate law enforcement, regulatory, and state professional licensing authorities.

(Sec. 3) Amends the Public Health Service Act to revise and reauthorize through FY2020 the controlled substance monitoring program, including to:

allow grants to be used to maintain and operate existing state controlled substance monitoring programs,
require the Department of Health and Human Services (HHS) to redistribute any funds that are returned among the remaining grantees,
require a state to provide HHS with aggregate data and other information to enable HHS to evaluate the success of the state's program, and
expand the program to include any commonwealth or territory of the United States.

Allows the Drug Enforcement Administration, HHS, a state Medicaid program, a state health department, or a state substance abuse agency receiving nonidentifiable information from a controlled substance monitoring database for research purposes to make that information available to other entities for research purposes.

Requires a state receiving a grant to: (1) facilitate prescriber and dispenser use of the state's controlled substance monitoring system, and (2) educate prescribers and dispensers on the benefits of the system both to them and society.

What's happening now September 9, 2015

Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Committees of jurisdiction 3